Zomedica Appoints Robert Cohen CEO as Company Nears Commercialization of TRUFORMA™

Go back to Zomedica Appoints Robert Cohen CEO as Company Nears Commercialization of TRUFORMA™
(NYSE: ZOM) Delayed: 0.10 --0 (-0%)
Previous Close $0.10    52 Week High $ 
Open $0.10    52 Week Low $ 
Day High $0.10    P/E N/A 
Day Low $0.10    EPS $ 
Volume 3,192       

(NYSE: ZOM) Delayed: 0.10 --0 (-0%)
Previous Close $0.10    52 Week High $ 
Open $0.10    52 Week Low $ 
Day High $0.10    P/E N/A 
Day Low $0.10    EPS $ 
Volume 3,192